Ledger.
Investor · Wayne, PA

David W. Menard

Open David in the network graph →
Filings
14
SEC Form D
Connections
23
co-filers
Capital
across filings
Active
Aug 2009
to Apr 2014

Most-connected co-filers (23)

Fernando J. Reinach · EMERYVILLE, CA12 sharedTim A. Scott · Knoxville, TN12 sharedJoel Cherry · EMERYVILLE, CA12 sharedBrian A. Dahn · IRVINE, CA11 sharedInderjit M. Singh · Grand Cayman, Cayman Islands11 sharedElizabeth T. Gile · New York, NY11 sharedDahn America360, LLC · IRVINE, CA11 sharedGeorge R. Sprenkle · Wayne, PA9 sharedLawrence J. Corr · Wayne, PA8 sharedCraig H. Dees · Knoxville, TN7 sharedStuart Fuchs · Knoxville, TN6 sharedRaffi Asadorian · EMERYVILLE, CA6 sharedGeoffrey J. Duyk · EMERYVILLE, CA6 sharedRaleigh A. Shoemaker · BOSTON, MA5 sharedPhilippe Boisseau · EMERYVILLE, CA5 sharedNancy K. Naeve · IRVINE, CA5 sharedRichard Godfrey · VANCOUVER, British Columbia, Canada2 sharedDouglas M. Lurio · Philadelphia, PA2 sharedCharles J. Arntzen · Columbia, MD2 sharedPaul Cox · VANCOUVER, British Columbia, Canada2 sharedAndrew Winston · VANCOUVER, British Columbia, Canada2 sharedEris A. Wachter · Knoxville, TN1 sharedPeter R. Culpepper · Knoxville, TN1 shared

Recent filings (14)

PROVECTUS BIOPHARMACEUTICALS, INC.Apr 2014 · 12 co-filers$5.0MPROVECTUS PHARMACEUTICALS INCSep 2013 · 12 co-filers$16.0MPROVECTUS PHARMACEUTICALS INCMar 2013 · 11 co-filers$2.5MPROVECTUS PHARMACEUTICALS INCNov 2012 · 12 co-filers$5.0MPROVECTUS PHARMACEUTICALS INCAug 2012 · 12 co-filers$5.0MPROVECTUS PHARMACEUTICALS INCMar 2012 · 11 co-filers$2.5MPROVECTUS PHARMACEUTICALS INCMay 2011 · 11 co-filers$5.0MPROVECTUS PHARMACEUTICALS INCMay 2010 · 11 co-filers$1.0MPROVECTUS PHARMACEUTICALS INCApr 2010 · 11 co-filers$1.3MPROVECTUS PHARMACEUTICALS INCMar 2010 · 11 co-filers$10.4MPROVECTUS PHARMACEUTICALS INCMar 2010 · 11 co-filers$10.0MMORO CORPJan 2010 · 7 co-filers$2.0MMORO CORPDec 2009 · 7 co-filers$2.0MPROVECTUS PHARMACEUTICALS INCAug 2009 · 11 co-filers$4.5M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See David in the interactive graph →